John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 4,545 shares at $32.68 ($153K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Scheduled sale ($153k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.68 | 1,400 | $46K | 29.9% |
| 2 | $33.32 | 800 | $27K | 17.4% |
| 3 | $34.43 | 2,345 | $81K | 52.7% |
| Total | $33.70 avg | 4,545 | $153K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |